宠物创新药
Search documents
明日开讲 | 媒体+大咖教您破解宠业流量密码,玩转抖音小红书
Nan Fang Nong Cun Bao· 2025-12-19 13:01
但多数宠业从业 者面临两大痛 点:一是看不清 市场增长新方 向,错失细分赛 道机遇;二是不 懂新媒体运营逻 辑,难以通过抖 音、小红书、视 频号精准触达目 明日开讲 | 媒体 +大咖教您破解 宠业流量密码, 玩转抖音小红书 _南方+_南方 plus 随着"它经济"崛 起,宠物消费从 基础温饱向健康 医疗、品质生 活、情感陪伴全 面升级,万亿市 场蓝海持续扩 容。 标客群。 为破解行业痛 点,赋能宠业人 把握发展红利, 12月20日14:30- 17:00,由南方 农村报主办,农 语(广州)现代 农业有限公司、 广州大洋教育科 技股份有限公司 联合协办的大湾 区宠物行业年度 盛典,重磅启幕 公益直播专场! 本次直播将聚焦 市场趋势与新媒 体实操,为宠业 从业者搭建高效 学习交流平台, 助力破局增长。 01 活动亮点 1、双维度深度 拆解:既解读宠 物经济市场纵深 与未来增长点, 又手把手教学三 大平台账号搭建 全流程,从宏观 趋势到实操落地 一站式覆盖。 2、实战派大咖 坐镇:两位拥有 丰富行业经验的 讲师联手,用真 实案例与落地方 法赋能宠业人。 3、精准解决痛 点:针对宠业门 店引流难、账号 起号慢、运营踩 ...
融资丨陕西天宠获Pre-A轮数千万级融资
Sou Hu Cai Jing· 2025-06-11 12:37
Financing Event - On June 10, Shaanxi Tiancare announced the completion of a Pre-A round financing of several tens of millions, exclusively invested by Xi'an Urban Agriculture Investment Co., Ltd [3] - The financing will focus on the research and development of innovative pet pharmaceuticals, the industrialization of biological agents, and the construction of an internationally leading GMP production base [3] Company Overview - Shaanxi Tiancare Biotechnology Co., Ltd was established in 2016, specializing in the research, production, and sales of innovative pet drugs and high-end pet medical products [5] - The company has established a municipal-level pet drug engineering research and development center and an experimental animal base, forming an innovative pattern of "two schools and one enterprise" [5] - The research pipeline covers six major areas: parasitology, oncology, endocrinology, anti-infection, and anti-inflammatory analgesia [5] Collaborations - Shaanxi Tiancare has established a "Pet Drug Creation Joint Laboratory" in collaboration with China Pharmaceutical University, focusing on the development of new sustained-release chemical drug formulations [7] - The company is also collaborating deeply with Northwest A&F University to make breakthroughs in key technologies for recombinant protein drugs in the field of biological agents [7] - The first cat subunit vaccine biological agent has completed preclinical research and is expected to be launched in 2027 [7] Investor Overview - Xi'an Urban Agriculture Investment Co., Ltd was established in September 2023 with a registered capital of 1 billion RMB, serving as a wholly-owned subsidiary of Xi'an Agricultural Investment Group [9] - The company focuses on capital operation, industrial investment, and financial services, aiming to build a 3+1+X urban agricultural investment system centered on "industrial investment + park incubation + supply chain finance" [9]